English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: Skin cancer, which is the most common form of all neoplasms worldwide. Most of patients with cancer may experience several hematological problems, low hemoglobin levels particularly. Although the prognosis of skin cancer is good, it is still unknown that whether skin cancer has an effect on blood parameters. In this study, we aimed to investigate possible differences in hemoglobin levels of patients with skin cancer and healthy individuals. Methods: We retrospectively analyzed medical data of 538 patients with skin cancer and 227 healthy individuals who presented to Check-Up Outpatient Clinic between January 2005 and January 2013. Baseline hemoglobin and hematocrit levels in patients with skin cancer were recorded. Comparison was based on t-test, ANOVA and Chi-square. Results: We observed a significant difference in hemoglobin and hematocrit levels between the groups (p<0.001). Conclusion: We measured hemoglobin and hematocrit levels were found to be within normal range although we found a significant difference in hemoglobin and hematocrit levels among the patients with skin cancer and healthy individuals.

turkish journal of biochemistry

An evaluation of hemoglobin and hematocrit levels among the patients with skin cancer and healthy individuals / [Cilt kanserli hastalardaki hemoglobin ve hematokrit seviyesinin sağlıklı kişilerle karşılaştırılması]